Text of section effective until April 01, 2025
Sec. 538.054.  ANALYSIS OF CLINICAL INITIATIVES.  The commission shall conduct an analysis of each clinical initiative selected by the commission after having conducted the commission's preliminary review under Section 538.053(4).  The analysis required under this section must include a review of:
(1)  any public comments and submitted research relating to the initiative;
(2)  the available clinical research and historical utilization information relating to the initiative;
(3)  published medical literature relating to the initiative;
(4)  any adoption of the initiative by medical societies or other clinical groups;
(5)  whether the initiative has been implemented under:
(A)  the Medicare program;
(B)  another state medical assistance program; or
(C)  a state-operated health care program, including the child health plan program;
(6)  the results of reports, research, pilot programs, or clinical studies relating to the initiative conducted by:
(A)  institutions of higher education, including related medical schools;
(B)  governmental entities and agencies; and
(C)  private and nonprofit think tanks and research groups;
(7)  the impact that the initiative would have on Medicaid if the initiative were implemented in this state, including:
(A)  an estimate of the number of recipients under Medicaid that would be impacted by implementation of the initiative; and
(B)  a description of any potential cost savings to the state that would result from implementation of the initiative; and
(8)  any statutory barriers to implementation of the initiative.
Added by Acts 2013, 83rd Leg., R.S., Ch. 619 (S.B. 1542), Sec. 1, eff. June 14, 2013.
Amended by: 
Acts 2015, 84th Leg., R.S., Ch. 1 (S.B. 219), Sec. 2.274, eff. April 2, 2015.
Repealed by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 3.01(3), eff. April 1, 2025.